NCT07746726 — "Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults" trial site landscape

Public-registry site landscape for NCT07746726, “Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults”, a Neuromuscular Blockade study sponsored by Jiangsu HengRui Medicine Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07746726 (registry record)
Study title	Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults
Official title	A Phase III, Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Bolus-Administered HRS-9190 Versus Rocuronium for Tracheal Intubation and Maintaining Neuromuscular Blockade During General Anesthesia in Adults Undergoing Elective Surgery
Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Condition(s)	Neuromuscular Blockade
Phase	PHASE3
Listed sites	2
Site countries	China

Patient-friendly overview of this study: eichor.com/study/NCT07746726.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07746726 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →